ACP
JNJ icon

Arcus Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Arcus Capital Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Sell
2,419
-34
-1% -$7.92K 0.25% 54
2026
Q1 		$600K Sell
2,453
-109
-4% -$25.4K 0.22% 65
2025
Q4 		$530K Buy
2,562
+109
+4% +$21.6K 0.19% 80
2025
Q3 		$455K Buy
2,453
+34
+1% +$5.83K 0.2% 72
2025
Q2 		$370K Hold
2,419
– – 0.16% 86
2025
Q1 		$401K Buy
2,419
+4
+0.2% +$626 0.16% 79
2024
Q4 		$382K Sell
2,415
-4
-0.2% -$620 0.12% 75
2024
Q3 		$392K Sell
2,419
-760
-24% -$121K 0.14% 75
2024
Q2 		$465K Buy
3,179
+764
+32% +$114K 0.18% 71
2024
Q1 		$382K Hold
2,415
– – 0.12% 75
2023
Q4 		$379K Hold
2,415
– – 0.13% 71
2023
Q3 		$376K Hold
2,415
– – 0.12% 77
2023
Q2 		$400K Sell
2,415
-2
-0.1% -$323 0.12% 73
2023
Q1 		$375K Hold
2,417
– – 0.13% 74
2022
Q4 		$427K Hold
2,417
– – 0.17% 59
2022
Q3 		$395K Sell
2,417
-94
-4% -$15.9K 0.17% 67
2022
Q2 		$446K Buy
2,511
+2
+0.1% +$356 0.2% 61
2022
Q1 		$445K Sell
2,509
-93
-4% -$15.8K 0.16% 62
2021
Q4 		$445K Buy
2,602
+778
+43% +$127K 0.15% 64
2021
Q3 		$295K Sell
1,824
-165
-8% -$28.1K 0.11% 82
2021
Q2 		$328K Sell
1,989
-570
-22% -$94.4K 0.15% 85
2021
Q1 		$421K Sell
2,559
-122
-5% -$19.7K 0.03% 73
2020
Q4 		$422K Buy
+2,681
New +$396K 0.06% 67
2019
Q3 		– Sell
-1,292
Closed -$180K – 115
2019
Q2 		$180K Buy
+1,292
New +$179K 0.07% 94
2018
Q1 		– Sell
-2,514
Closed -$351K – 114
2017
Q4 		$351K Buy
2,514
+770
+44% +$107K 0.2% 75
2017
Q3 		$227K Buy
+1,744
New +$231K 0.12% 99

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Arcus Capital Partners's JNJ Position: Q2 2026 in Review

Arcus Capital Partners reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2026, selling an estimated $7.92K and leaving 2,419 shares worth $614K. The position accounts for 0.25% of the portfolio, ranked #54.

Arcus Capital Partners first reported a position in JNJ in Q3 2017 and has held it in 26 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Arcus Capital Partners held 2,419 shares of Johnson & Johnson worth $614K as of Q2 2026.
  • Arcus Capital Partners sold 34 Johnson & Johnson shares in Q2 2026, an estimated $7.92K.
  • Johnson & Johnson made up 0.25% of Arcus Capital Partners's portfolio in Q2 2026, its #54 holding.
  • Arcus Capital Partners first reported a position in Johnson & Johnson in Q3 2017 and has held it in 26 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Arcus Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.